Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lean Efficacy Phase IIa Proof of Concept Trial (LEAAP). A Study in Overweight and Obese Patients During Twenty-six Weeks, Investigating the Effect of EMP16-02 on Body Weight, Safety and Clinical Biomarkers

Next Previous
Trial Profile

Lean Efficacy Phase IIa Proof of Concept Trial (LEAAP). A Study in Overweight and Obese Patients During Twenty-six Weeks, Investigating the Effect of EMP16-02 on Body Weight, Safety and Clinical Biomarkers

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 24 Dec 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Acarbose/orlistat (Primary)
  • Indications Obesity
  • Focus Biomarker; Proof of concept; Therapeutic Use
  • Sponsors Empros Pharma

Most Recent Events

  • 04 Nov 2022 Results of six month follow up, presented at The Obesity Society: ObesityWeek 2022.
  • 19 Sep 2022 Primary endpoint has been met (Body weight, relative (%) change from baseline for EMP16-02 (120 mg O/40 mg A)) , according to Results published in the Obesity (Silver Spring, Md.)
  • 19 Sep 2022 Results published in the Obesity (Silver Spring, Md.)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top